EX-10.2 3 ex-10d2.htm EX-10.2 AXOGEN, INC. NON–QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENTQualified Stock Option Inducement Award Agreement • May 5th, 2020 • Minnesota
This Non–Qualified Stock Option Inducement Award Agreement (the “Agreement”), effective as of this 17th day of July 2017 (the “Effective Date”), by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and Jon Gingrich (“Optionee”) is made in connection with the Optionee’s entry into employment within the meaning of Rule 5635(c)(4) of the NASDAQ Listing Rules. If and to the extent that this Agreement conflicts or is inconsistent with the terms, conditions and provisions of any employment, consulting or similar services agreement between the Optionee and the Company as may be in effect (the “Service Agreement”), the Service Agreement shall control, and this Agreement shall be deemed to be modified accordingly. Capitalized terms used but not defined herein shall have the meanings set forth in that certain Employment Agreement by and between the Company and the Optionee dated as of July 17, 2017 (the “Employment Agreement”).
Recro Pharma, Inc. Non-Qualified Stock Option Inducement Award AgreementQualified Stock Option Inducement Award Agreement • August 9th, 2021 • Recro Pharma, Inc. • Pharmaceutical preparations
We are pleased to advise you that Recro Pharma, Inc. (the “Company”) hereby awards to you the right to purchase (an “Option”) the number of shares of Common Stock of the Company (“Shares”), as set forth on the grant schedule attached hereto (the “Grant Schedule”), subject to your signing this Award Agreement (this “Agreement”). The date of award of the Option shall for all purposes be the date set forth on the Grant Schedule (the “Grant Date”). The Option issued hereunder is a “non-qualified stock option” for tax purposes.
